Table 4.
The Results of QCMD 2020 Coronavirus Outbreak Preparedness EQA Pilot Study Sample Panel with the Evaluated Methods
| Sample | Matrix | Sample content | Result with the cobas SARS-CoV-2 test | Result with the Amplidiag COVID-19 test | Result with the LDT | dPCR log10 copies/mL | Sample status |
|---|---|---|---|---|---|---|---|
| CVOP20S-01 | TM | SARS-CoV-2 | Positive | Positive | Positive | 4.30 | Positive |
| CVOP20S-02 | TM | Coronavirus-NL63 | Negative | Failed | Negative | 4.64 | Positive |
| CVOP20S-03 | TM | SARS-CoV-2 | Positive | Failed | Positive | 3.30 | Positive |
| CVOP20S-04 | TM | Coronavirus-OC43 | Negative | Failed | Negative | 4.03 | Positive |
| CVOP20S-05 | TM | Negative | Negative | Failed | Negative | Negative | |
| CVOP20S-06 | TM | SARS-CoV-2 | Positive | Positive | Positive | 4.30 | Positive |
| CVOP20S-07 | TM | SARS-CoV-2 | Positive | Positive | Positive | 5.30 | Positive |
| CVOP20S-08 | TM | SARS-CoV-2 | Positive | Positive | Positive | 2.30 | Borderline positive |
dPCR, digital PCR; TM, transport medium.
COVID-19, coronavirus disease 2019; LDT, laboratory-developed test; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.